|
2008 Journal Article Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment responseBarbour, A.P., Jones, M., Gonen, M., Gotley, D.C., Thomas, J., Thomson, D.B., Burmeister, B. and Smithers, B.M. (2008). Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response. Annals of Surgical Oncology, 15 (10), 2894-2902. doi: 10.1245/s10434-008-0084-y |
|
2008 Journal Article Consideration of mesh-related complications: Letters and commentsShenfine, Jon, Barbour, Andrew, Martin, Ian, Smithers, B. Mark and Gotley, David C. (2008). Consideration of mesh-related complications: Letters and comments. Annals of the Royal College of Surgeons of England, 90 (2), 175-176. doi: 10.1308/003588408X261780 |
|
2008 Book Clinical practice guidelines for the management of melanoma in Australia and New ZealandAitken, Joanne F., Barbour, Andrew, Burmeister, Bryan, Taylor, Simon, Walpole, Euan, Australian Cancer Network, Smithers, Bernhard M. and Melanoma Guidelines Revision Working Party (2008). Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Sydney, Australia: Cancer Council Australia; Australian Cancer Network; Ministry of Health, New Zealand. |
|
2008 Conference Publication Minimally invasive esophagectomy for esophageal cancer: Analysis of recurrence patterns and prognostic factors of recurrenceBarbour, A., Thompson, I., Gotley, D. C., Jones, M., Thomas, J., Martin, I. and Smithers, M. B. (2008). Minimally invasive esophagectomy for esophageal cancer: Analysis of recurrence patterns and prognostic factors of recurrence. Clinical Oncological Society of Australia and the International Association of Cancer Registries Joint Scientific Meeting, held in conjunction with the Australian and New Zealand Gastro-Oesophageal Surgery Association, Sydney, Australia, 18–20 November 2008. United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/j.1743-7563.2008.00201_2.x |
|
2008 Conference Publication A randomised phase II trial comparing pre-operative chemotherapy with pre-operative chemoradiation therapy for localized carcinoma of the oesophagusBurmeister, B. H., Smithers, B. M., Thomas, J., Burmeister, E., Walpole, E., Harvey, J., Thomson, D., Barbour, A. and Gotley D. (2008). A randomised phase II trial comparing pre-operative chemotherapy with pre-operative chemoradiation therapy for localized carcinoma of the oesophagus. Clinical Oncological Society of Australia and the International Association of Cancer Registries Joint Scientific Meeting, held in conjunction with the Australian and New Zealand Gastro-Oesophageal Surgery Association, Sydney, Australia, 18-20 November 2008. United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1743-7563.2008.00201_1.x |
|
2008 Journal Article Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomyBarbour, A.P., Lagergren, P., Hughes, R., Alderson, D., Barham, C.P. and Blazeby, J.M. (2008). Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. British Journal of Surgery, 95 (1), 80-84. doi: 10.1002/bjs.5912 |
|
2007 Journal Article Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junctionBarbour, Andrew P., Rizk, Nabil P., Gerdes, Hans, Bains, Manjit S., Rusch, Valerie W., Brennan, Murray F. and Coit, Daniel G. (2007). Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. Journal of the American College of Surgeons, 205 (4), 593-601. doi: 10.1016/j.jamcollsurg.2007.05.010 |
|
2007 Journal Article Adenocarcinoma of the gastroesophageal junction: Influence of esophageal resection margin and operative approach on outcomeBarbour, Andrew P., Rizk, Nabil P., Gonen, Mithat, Tang, Laura, Bains, Manjit S., Rusch, Valerie W., Coit, Daniel G. and Brennan, Murray F. (2007). Adenocarcinoma of the gastroesophageal junction: Influence of esophageal resection margin and operative approach on outcome. Annals of Surgery, 246 (1), 1-8. doi: 10.1097/01.sla.0000255563.65157.d2 |
|
2007 Journal Article Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): Impact of adequate staging on outcomeBarbour, Andrew P., Rizk, Nabil P., Gonen, Mithat, Tang, Laura, Bains, Manjit S., Rusch, Valerie W., Coit, Daniel G. and Brennan, Murray F. (2007). Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): Impact of adequate staging on outcome. Annals of Surgical Oncology, 14 (2), 306-316. doi: 10.1245/s10434-006-9166-x |
|
2007 Journal Article Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapySmithers, B. M., Cullinan, M., Thomas, J. M., Martin, I., Barbour, A. P., Burmeister, B. H., Harvey, J. A., Thomson, D. B., Walpole, E. T. and Gotley, D. C. (2007). Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy. Diseases of The Esophagus, 20 (6), 471-477. doi: 10.1111/j.1442-2050.2007.00701.x |
|
2007 Conference Publication Surgery for early esophageal adenocarcinoma: Analysis of lymphatic spread and prognostic factorsHughes, A., Smithers, B. M., Thomas, J., Martin, I., Gotley, D. C. and Barbour, A. P. (2007). Surgery for early esophageal adenocarcinoma: Analysis of lymphatic spread and prognostic factors. 60th Annual Cancer Symposium of the Society of Surgical Oncology, Washington, DC, USA, 15-18 Mar, 2007. Hagerstown, U.S.A.: Springer. |
|
2006 Conference Publication Isolated limb infusion (ILI) for malignant melanoma: Predictors of response and outcomeBarbour, A.P., Beller, E. and Smithers, B.M. (2006). Isolated limb infusion (ILI) for malignant melanoma: Predictors of response and outcome. The 59th Annual Cancer Symposium of the Society of Surgical Oncology, San Diego, CA, 23-26 March 2006. Hagerstown, U.S.A.: Springer. |
|
2006 Conference Publication Refining oesophageal cancer staging after neoadjuvant therapy: importance of primary tumour responseBarbour, A. P., Smithers, B. M., Gotley, D. C., Thomas, J., Burmeister, B. H. and Thompson, D. (2006). Refining oesophageal cancer staging after neoadjuvant therapy: importance of primary tumour response. The RACS Annual Scientific Congress, Sydney Convention & Exhibition Centre, Darling Harbour, Sydney, 15-19 May, 2006. Australia: Blackwell Publishing Asia. |
|
2006 Conference Publication Patterns and predictors of initial recurrence following resection for adenocarcinoma of the oesophagus and gastro-oesophageal junctionBarbour, A. P., Smithers, B. M., Gotley, D. C., Thomas, J., Burmeister, B. H. and Walpole, E. T. (2006). Patterns and predictors of initial recurrence following resection for adenocarcinoma of the oesophagus and gastro-oesophageal junction. The RACS Annual Scientific Congress, Sydney Convention & Exhibition Centre, Darling Harbour, Sydney, 15-19 May 2006. Australia: Blackwell Publishing Asia. |
|
2006 Conference Publication Isolated limb infusion (ILT) for malignant melanoma: Predictors of response and outcomeBarbour, AP, Beller, E and Smithers, BM (2006). Isolated limb infusion (ILT) for malignant melanoma: Predictors of response and outcome. 59th Annual Cancer Symposium of the Society-of-Surgical-Oncology, San Diego CA, MAR 23-26, 2006. NEW YORK: SPRINGER. |
|
2003 Journal Article Current concepts of tumour metastasisBarbour, A. and Gotley, D. C. (2003). Current concepts of tumour metastasis. Annals Academy of Medicine Singapore, 32 (2), 176-184. |
|
2003 Journal Article Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3Barbour, A. P., Reeder, J. A., Walsh, M. D., Fawcett, J., Antalis, T. M. and Gotley, D. C. (2003). Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3. Cancer Research, 63 (4), 887-892. |
|
2000 Conference Publication Glycosaminoglycan-modified CD44v3 confers a metastatic phenotype on a human hepatocellular carcinoma (HCC) cell line in a murine modelBarbour, A., Reeder, J., Fawcett, J., Walsh, M., Antalis, T. M. and Gotley, D. C. (2000). Glycosaminoglycan-modified CD44v3 confers a metastatic phenotype on a human hepatocellular carcinoma (HCC) cell line in a murine model. 91st Annual Meeting of American Association for Cancer Research, San Francisco, 1-5 Apr, 2000. Philadelphia, U.S.A.: American Association for Cancer Research. |
